Proceeds will fund planned further clinical development of its lead asset, OXU-001, for the treatment of diabetic macular edema (DME), as well as accelerating the development of its early-product ...

Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.

The “Pharmaceutical Clinical Contract Peripheral Services, 2025-2030” report has been added to ResearchAndMarkets.com’s offering. Global CRO industry was valued at $66.39 billion in 2024, and it is ...

Sexual activity should be enjoyable and healthy. As people enter their 50s, it is natural for some aspects of intimacy to change. Men are finding ways to enhance their intimate lives without having to ...

New applications include proximal/distal biceps tenodesis, insertional Achilles tendinopathy, gluteus medius and proximal hamstring reattachment, lateral epicondyle repair, and subscapularis repair ...

This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was ...

As modern sound therapy gains entry among the healing methods that complement the therapies, it achieves acknowledgment in the contemporary practices of therapy. Singing bowls and gongs—previously ...

Taking care of our family and loved ones throughout their lives is a key facet of human connection. However, there may come a time, whether due to disease, age, or other inevitability, they could ...

Providing support at home can be a necessary part of our loved ones’ care, but what do you need to know about this service near New York City?

DREAM OCT is able to cover an ultrawide field single scan which delivers a 130° OCTA image. DREAM OCT™ swept-source 12 mm super-depth scanning allows superior imaging of the choroid and retina, and a ...

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...